HIV prevention network coordinating center
Official title: HIV Prevention Trials Network Leadership and Operations Center
Funded at Family Health International · NIH-11466551 · Data updated 2026-11-12
This program runs and supports studies of new long-acting HIV prevention medicines and combined products for people at risk, including young adults, men who have sex with men, transgender women, sex workers, and people who inject drugs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Family Health International NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | June 1, 2006 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $10,480 |
| NIH project number | 3UM1AI068619-20S1 |
| Project ID | NIH-11466551 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are HIV-negative people at higher risk for HIV—for example sexually active young adults, men who have sex with men, transgender women, female sex workers, people who inject drugs, and women in high-incidence regions—who can attend a participating clinic.
✕Less likely to help
People already living with HIV or those not at risk for HIV are not the primary focus and are unlikely to benefit from these prevention studies.
What this research studies
From a patient perspective, this program designs and runs clinical studies to find HIV prevention options that are safe, acceptable, and easy to use. It focuses on long-acting antiretroviral approaches for PrEP, multipurpose products that may also prevent pregnancy or other STIs, and antibody-based strategies. The network works with clinical sites in the U.S. and around the world, including sub-Saharan Africa, and partners with other HIV research groups. If invited, you would visit a participating clinic where staff would explain the prevention product, study procedures, and safety monitoring.
Why it matters
Potential benefit: If successful, the work could deliver longer-lasting, more convenient HIV prevention options and combined products that reduce HIV and other risks.
How similar studies have gone: Earlier prevention efforts like daily oral PrEP and long-acting injectable cabotegravir have shown clear protection, while multipurpose products and some antibody approaches are newer and less proven.
Where this research is happening
-
Family Health International
Durham, United States Active
Researchers
- Principal investigator: Landovitz, Raphael J — Family Health International
- Study coordinator: Landovitz, Raphael J
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.